12 results
DEFA14A
CNTA
Centessa Pharmaceuticals plc
20 May 24
Additional proxy soliciting materials
8:48pm
Transactions, and Director Independence - under the subheading Indemnification Agreements – p.175 with the form of indemnity provided shown in Part II, Item … independence. 1 Fees charged in respect of advisory services relating to the directors’ remuneration only. Activities of the Remuneration Committee
PRE 14A
CNTA
Centessa Pharmaceuticals plc
26 Apr 24
Preliminary proxy
4:36pm
that the provision of such services was compatible with the maintenance of each firm’s independence in the conduct of its auditing functions. Audit … . are independent, as determined in accordance with the rules of Nasdaq. In making such independence determination, our Board of Directors considered
DEFA14A
tvycrqorsapf 0taxz3y
23 May 23
Additional proxy soliciting materials
4:08pm
DEFA14A
rv2frcad
9 Jun 22
Additional proxy soliciting materials
9:06am
DEF 14A
u0esylbe
23 May 22
Definitive proxy
8:00am
10-K
EX-10.35
2j96oj
30 Mar 22
Annual report
12:00am
- Prev
- 1
- Next